Clinical Trial Update: A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection [Phase 2]

View source ↗

Summary

Phase 2 study evaluating teropavimab and zinlirvimab in combination with lenacapavir for virologically suppressed adults with HIV-1 infection; results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• SUNLENCA (LENACAPAVIR SODIUM)
• Teropavimab (teropavimab)
• Zinlirvimab (zinlirvimab)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infection | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-07-15